Pharmacological enhancement of fear reduction: preclinical models
نویسندگان
چکیده
منابع مشابه
Fear of Crime and Fear Reduction Strategies
This Trends and Issues on fear of crime, and its reduction in Australia, represents an outstanding illustration of the contribution which criminological research can make to public policy. Various surveys in recent years have identified a number of factors consistently associated with fear of crime. These are gender (females tend to be more fearful than males) and the presence of disorder and i...
متن کاملPotential Role of Local Estrogen in Enhancement of Fracture Healing: Preclinical Study in Rabbits
Background: Effects of estrogen on bone metabolism and its protective role on prevention of osteoporosis are well documented. However, the efficacy of estrogen treatment on bone healing is not well investigated. The drug can be delivered both systemically or locally to the bone with differences in concentrations and side effects. The aim of this study was to investigate the effect of lo...
متن کاملEmerging preclinical pharmacological targets for Parkinson's disease
Parkinson's disease (PD) is a progressive neurological condition caused by the degeneration of dopaminergic neurons in the basal ganglia. It is the most prevalent form of Parkinsonism, categorized by cardinal features such as bradykinesia, rigidity, tremors, and postural instability. Due to the multicentric pathology of PD involving inflammation, oxidative stress, excitotoxicity, apoptosis, and...
متن کاملPreclinical pharmacological evaluation of a novel multiple kinase inhibitor, ON123300, in brain tumor models.
ON123300 is a low molecular weight multikinase inhibitor identified through a series of screens that supported further analyses for brain tumor chemotherapy. Biochemical assays indicated that ON123300 was a strong inhibitor of Ark5 and CDK4, as well as growth factor receptor tyrosine kinases such as β-type platelet-derived growth factor receptor (PDGFRβ). ON123300 inhibited U87 glioma cell prol...
متن کاملNoradrenergic enhancement of amygdala responses to fear.
Multiple lines of evidence implicate the basolateral amygdala (BLA) and the noradrenergic (norepinephrine, NE) system in responding to stressful stimuli such as fear signals, suggesting hyperfunction of both in the development of stress-related pathologies including anxiety disorders. However, no causative link between elevated NE neurotransmission and BLA hyperresponsiveness to fear signals ha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Pharmacology
سال: 2011
ISSN: 0007-1188
DOI: 10.1111/j.1476-5381.2010.01175.x